NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY) Short Interest Down 19.2% in February

NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY) was the target of a significant decrease in short interest during the month of February. As of February 28th, there was short interest totalling 89,000 shares, a decrease of 19.2% from the February 13th total of 110,200 shares. Based on an average daily volume of 234,600 shares, the days-to-cover ratio is currently 0.4 days. Approximately 2.1% of the company’s stock are short sold.

NovaBay Pharmaceuticals Price Performance

NovaBay Pharmaceuticals stock opened at $0.60 on Thursday. The stock has a market cap of $2.54 million, a PE ratio of -0.06 and a beta of 2.82. NovaBay Pharmaceuticals has a one year low of $0.36 and a one year high of $9.08.

NovaBay Pharmaceuticals Company Profile

NovaBay Pharmaceuticals, Inc develops and sells eyecare and wound care products in the United States and internationally. It offers Avenova Spray, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; Avenova Eye Health Support antioxidant-rich oral supplements; Avenova Lubricating Eye Drops for instant relief; NovaWipes by Avenova; Avenova WarmEye Compress to soothe the eyes; and the i-Chek by Avenova to monitor physical eyelid health.